Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Obstetrics and Gynecology Reports
Erschienen in: Current Obstetrics and Gynecology Reports 2/2016

12.04.2016 | Pelvic Organ Prolapse (M Weinstein, Section Editor)

Quality Measures for Prolapse Management

verfasst von: Caroline Foust-Wright, Patricia Hudson, Samantha Pulliam

Erschienen in: Current Obstetrics and Gynecology Reports | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Quality measure development has become increasingly important over the past few years, and there have been many attempts to increase the scientific literature on the subject. Measurement of quality is now an integral part of the healthcare system. This review considers recently recommended quality metrics for prolapse management, subdividing these into structural, process, and outcome metrics. The Quality in Prolapse Surgery (QuIPS) project, Choosing Wisely® campaign by the American Board of Internal Medicine (ABIM), quality measures proposed by AUGS, and the 2012 joint report from IUGA and International Continence Society (ICS) are included this review. Evaluation of adherence to quality metrics is also discussed.
Literatur
1.•
Wu JM, Matthews CA, Conover MM, Pate V, Jonsson FM. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol. 2014;123(6):1201–6. Provided updated numbers for the lifetime risk of surgery for prolapse or incontinence.CrossRefPubMedPubMedCentral
2.
Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501–6.CrossRefPubMed
3.
Fialkow MF, Newton KM, Lentz GM, Weiss NS. Lifetime risk of surgical management for pelvic organ prolapse or urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(3):437–40.CrossRefPubMed
4.
5.
Wright JD. Measuring what matters: quality in gynecologic surgery. Am J Obstet Gynecol. 2015;212(3):257–8.CrossRefPubMed
6.
Birkmeyer JD, Dimick JB, Birkmeyer NJ. Measuring the quality of surgical care: structure, process, or outcomes? J Am Coll Surg. 2004;198(4):626–32.CrossRefPubMed
7.
Rogo-Gupta LJ, Lewin SN, Kim JH, et al. The effect of surgeon volume on outcomes and resource use for vaginal hysterectomy. Obstet Gynecol. 2010;116(6):1341–7.CrossRefPubMed
8.
Mäkinen J, Johansson J, Tomás C, et al. Morbidity of 10 110 hysterectomies by type of approach. Hum Reprod. 2001;16(7):1473–8.CrossRefPubMed
9.•
Morgan DM, Pulliam S, Adam RA, et al. Analysis of high-, intermediate-, and low-volume surgeons when performing hysterectomy for uterovaginal prolapse. Female Pelvic Med Reconstr Surg. 2016;22(1):43–50. Discussed the differences in the quality of care based on surgical volume.CrossRefPubMed
10.
Pulliam SJ, Morgan DM, Guaderrama N, Guire K, Adam RA. Differences in patterns of preoperative assessment between high, intermediate, and low volume surgeons when performing hysterectomy for uterovaginal prolapse. Female Pelvic Med Reconstr Surg. 2015.
11.
Johnston MJ, Singh P, Pucher PH, et al. Systematic review with meta-analysis of the impact of surgical fellowship training on patient outcomes. Br J Surg. 2015;102(10):1156–66.CrossRefPubMed
12.
13.
Drutz HP, Committee IE. IUGA guidelines for training in female pelvic medicine and reconstructive pelvic surgery (FPM-RPS). Updated guidelines 2010. Int Urogynecol J. 2010;21(12):1445–53.CrossRefPubMed
14.•
Corona LE, Swenson CW, Sheetz KH, et al. Use of other treatments before hysterectomy for benign conditions in a statewide hospital collaborative. Am J Obstet Gynecol. 2015;212(3):304.e301–307. Highlighted that many surgeons are not exhausting alternative therapies prior to definitive treatment.CrossRef
15.
16.
17.•
Anger JT, Scott VC, Kiyosaki K, et al. Quality-of-care indicators for pelvic organ prolapse: development of an infrastructure for quality assessment. Int Urogynecol J. 2013;24(12):2039–47. Discussed the development of quality-of-care indicators for pelvic organ prolapse.CrossRefPubMedPubMedCentral
18.
19.
Teeluckdharry B, Gilmour D, Flowerdew G. Urinary tract injury at benign gynecologic surgery and the role of cystoscopy: a systematic review and meta-analysis. Obstet Gynecol. 2015;126(6):1161–9.CrossRefPubMed
20.
Visco AG, Taber KH, Weidner AC, Barber MD, Myers ER. Cost-effectiveness of universal cystoscopy to identify ureteral injury at hysterectomy. Obstet Gynecol. 2001;97(5 Pt 1):685–92.PubMed
21.
Vakili B, Chesson RR, Kyle BL, et al. The incidence of urinary tract injury during hysterectomy: a prospective analysis based on universal cystoscopy. Am J Obstet Gynecol. 2005;192(5):1599–604.CrossRefPubMed
22.
Walters MD, Ridgeway BM. Surgical treatment of vaginal apex prolapse. Obstet Gynecol. 2013;121(2 Pt 1):354–74.CrossRefPubMed
23.
Eilber KS, Alperin M, Khan A, et al. Outcomes of vaginal prolapse surgery among female Medicare beneficiaries: the role of apical support. Obstet Gynecol. 2013;122(5):981–7.CrossRefPubMed
24.••
Barber MD, Brubaker L, Burgio KL, et al. Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. JAMA. 2014;311(10):1023–34. Compared outcomes of uterosacral ligament suspension to sacrospinous ligament suspension.CrossRefPubMedPubMedCentral
25.
Clemons JL, Aguilar VC, Sokol ER, Jackson ND, Myers DL. Patient characteristics that are associated with continued pessary use versus surgery after 1 year. Am J Obstet Gynecol. 2004;191(1):159–64.CrossRefPubMed
26.
Sullivan SA, Davidson ER, Bretschneider CE, Liberty AL, Geller EJ. Patient characteristics associated with treatment choice for pelvic organ prolapse and urinary incontinence. Int Urogynecol J. 2015.
27.
Abdool Z, Thakar R, Sultan AH, Oliver RS. Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse. Int Urogynecol J. 2011;22(3):273–8.CrossRefPubMed
28.
Lamers BH, Broekman BM, Milani AL. Pessary treatment for pelvic organ prolapse and health-related quality of life: a review. Int Urogynecol J. 2011;22(6):637–44.CrossRefPubMedPubMedCentral
29.
30.••
Toozs-Hobson P, Freeman R, Barber M, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for reporting outcomes of surgical procedures for pelvic organ prolapse. Neurourol Urodyn. 2012;31(4):415–21. Proposed standardized terminology for reporting outcomes on pelvic organ prolapse.CrossRefPubMed
31.
Brubaker L, Cundiff GW, Fine P, et al. Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med. 2006;354(15):1557–66.CrossRefPubMed
32.
Rogers RG, Kammerer-Doak D, Villarreal A, Coates K, Qualls C. A new instrument to measure sexual function in women with urinary incontinence or pelvic organ prolapse. Am J Obstet Gynecol. 2001;184(4):552–8.CrossRefPubMed
33.
Practice Bulletin No. 149: endometrial cancer. Obstet Gynecol. 2015;125(4):1006–26.
34.
Kandadai P, Flynn M, Zweizig S, Patterson D. Cost-utility of routine endometrial evaluation before le fort colpocleisis. Female Pelvic Med Reconstr Surg. 2014;20(3):168–73.CrossRefPubMed
35.•
Srikrishna S, Robinson D, Cardozo L, Thiagamoorthy G. Patient and surgeon goal achievement 10 years following surgery for pelvic organ prolapse and urinary incontinence. Int Urogynecol J. 2015;26(11):1679–86. Discussed the differing expectations of surgeons and patients following surgery.CrossRefPubMed
36.
Srikrishna S, Robinson D, Cardozo L. A longitudinal study of patient and surgeon goal achievement 2 years after surgery following pelvic floor dysfunction surgery. BJOG. 2010;117(12):1504–11.CrossRefPubMed
37.
Barber MD, Kuchibhatla MN, Pieper CF, Bump RC. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol. 2001;185(6):1388–95.CrossRefPubMed
38.
Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005;193(1):103–13.CrossRefPubMed
39.
Rortveit G, Subak LL, Thom DH, et al. Urinary incontinence, fecal incontinence and pelvic organ prolapse in a population-based, racially diverse cohort: prevalence and risk factors. Female Pelvic Med Reconstr Surg. 2010;16(5):278–83.CrossRefPubMed
40.
Lawrence JM, Lukacz ES, Nager CW, Hsu JW, Luber KM. Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women. Obstet Gynecol. 2008;111(3):678–85.CrossRefPubMed
41.
Alas AN, Bresee C, Eilber K, et al. Measuring the quality of care provided to women with pelvic organ prolapse. Am J Obstet Gynecol. 2015;212(4):471.e471–479.CrossRef
42.
Rubin HR, Pronovost P, Diette GB. From a process of care to a measure: the development and testing of a quality indicator. Int J Qual Health Care. 2001;13(6):489–96.CrossRefPubMed
43.
Arrowood D, Choate E, Curtis E, et al. Integrity of the healthcare record. Best practices for EHR documentation. J AHIMA. 2013;84(8):58–62.PubMed
Metadaten
Titel
Quality Measures for Prolapse Management
verfasst von
Caroline Foust-Wright
Patricia Hudson
Samantha Pulliam
Publikationsdatum
12.04.2016
Verlag
Springer US
Erschienen in
Current Obstetrics and Gynecology Reports / Ausgabe 2/2016
Elektronische ISSN: 2161-3303
DOI
https://doi.org/10.1007/s13669-016-0160-4

Weitere Artikel der Ausgabe 2/2016

Current Obstetrics and Gynecology Reports 2/2016 Zur Ausgabe

Uterine Fibroids (N Narvekar, Section Editor)

Fibroids and Infertility

Pelvic Organ Prolapse (M Weinstein, Section Editor)

Concomitant Incontinence Surgery at the Time of Prolapse Repair

Pelvic Organ Prolapse (M Weinstein, Section Editor)

Native Tissue Surgery for Prolapse versus Graft/Mesh Use: Current Trends in Reconstructive Surgery

Pelvic Organ Prolapse (M Weinstein, Section Editor)

Epidemiology of Pelvic Organ Prolapse

Uterine Fibroids (N Narvekar, Section Editor)

Office Hysteroscopic Treatment of Uterine Fibroids

Uterine Fibroids (N Narvekar, Section Editor)

The Role of Complementary and Alternative Medicine for the Management of Fibroids and Associated Symptomatology

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise